ArticleFrontiers in medicine2025
Identifying sepsis susceptibility genes in post-surgical patients using an artificial intelligence approach.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
28 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Early detection of sepsis is essential for its successful management. Although genome-wide association studies (GWAS) have shown potential in identifying sepsis-related genetic variants, they often involve heterogeneous patient groups and use single-locus analysis methods. Here, we aim to identify new sepsis susceptibility loci in post-surgical patients using an explainable artificial intelligence (XAI) approach applied to GWAS data. Methods: GWAS was performed in 750 post-operative patients with sepsis and 3,500 population controls. We applied a novel XAI-based methodology to GWAS-derived single nucleotide polymorphisms (SNPs) to predict sepsis and prioritize new genetic variants associated with post-operative sepsis susceptibility. We also assessed functional and enrichment effects using empirical data from integrated software tools and datasets, with the top-ranked variants and associated genes. Results: Our XAI-GWAS approach showed a notable performance in predicting post-surgical sepsis and prioritized SNPs (such as rs17653532, rs1575081785, and rs74707084) with higher contribution to post-operative sepsis prediction. It also facilitated the discovery of post-operative sepsis risk loci with important functional implications related to gene expression regulation, DNA replication, cyclic nucleotide signaling, cell proliferation, and cardiac dysfunction. Conclusion: The combination of GWAS and XAI prioritized loci associated with post-operative sepsis susceptibility. The determination of key genes, such as
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.